Titre : Technique d'Ilizarov

Technique d'Ilizarov : Questions médicales fréquentes

Termes MeSH sélectionnés :

Carcinoma, Transitional Cell
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Technique d'Ilizarov : Questions médicales les plus fréquentes", "headline": "Technique d'Ilizarov : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Technique d'Ilizarov : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-16", "dateModified": "2025-04-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Technique d'Ilizarov" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Allongement osseux", "url": "https://questionsmedicales.fr/mesh/D001852", "about": { "@type": "MedicalCondition", "name": "Allongement osseux", "code": { "@type": "MedicalCode", "code": "D001852", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E04.555.120" } } }, "about": { "@type": "MedicalCondition", "name": "Technique d'Ilizarov", "alternateName": "Ilizarov Technique", "code": { "@type": "MedicalCode", "code": "D018889", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Aihemaitijiang Yusufu", "url": "https://questionsmedicales.fr/author/Aihemaitijiang%20Yusufu", "affiliation": { "@type": "Organization", "name": "Department of Trauma and Microreconstructive Surgery, The First Affiliated Hospital of Xinjiang Medical University, 830054, Urumqi, Xinjiang, China. ahmatjang@163.com." } }, { "@type": "Person", "name": "Piotr Morasiewicz", "url": "https://questionsmedicales.fr/author/Piotr%20Morasiewicz", "affiliation": { "@type": "Organization", "name": "Department and Clinic of Orthopaedic and Traumatologic Surgery, Wroclaw Medical University, Borowska 213, 50-556, Wroclaw, Poland." } }, { "@type": "Person", "name": "Maimaiaili Yushan", "url": "https://questionsmedicales.fr/author/Maimaiaili%20Yushan", "affiliation": { "@type": "Organization", "name": "Department of Orthopedic Surgery, The Fourth Affiliated Hospital of Xinjiang Medical University, Traditional Chinese Medicine Hospital of Xinjiang Uyghur Autonomous Region, Ürümqi, Xinjiang, People's Republic of China. 424257832@qq.com." } }, { "@type": "Person", "name": "Sihe Qin", "url": "https://questionsmedicales.fr/author/Sihe%20Qin", "affiliation": { "@type": "Organization", "name": "Department of Orthopedics, Rehabilitation Hospital, National Research Center for Rehabilitation, Beijing, China." } }, { "@type": "Person", "name": "Yanshi Liu", "url": "https://questionsmedicales.fr/author/Yanshi%20Liu", "affiliation": { "@type": "Organization", "name": "Department of Trauma and Microreconstructive Surgery, The First Affiliated Hospital of Xinjiang Medical University, 830054, Urumqi, Xinjiang, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors.", "datePublished": "2022-08-06", "url": "https://questionsmedicales.fr/article/36031535", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clgc.2022.08.001" } }, { "@type": "ScholarlyArticle", "name": "The osteoclast-type giant cell rich carcinoma of urinary bladder: A case series.", "datePublished": "2022-10-11", "url": "https://questionsmedicales.fr/article/36242968", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.prp.2022.154164" } }, { "@type": "ScholarlyArticle", "name": "The Association of P53, CK29, and FGFR3 Overexpression with the Characteristics of Urothelial Cell Carcinoma of the Bladder.", "datePublished": "2023-09-01", "url": "https://questionsmedicales.fr/article/37774064", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.31557/APJCP.2023.24.9.3125" } }, { "@type": "ScholarlyArticle", "name": "Urothelial carcinoma in situ with \"overriding\" features can evade detection by mimicking umbrella cells.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/36997033", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.humpath.2023.03.007" } }, { "@type": "ScholarlyArticle", "name": "Specific subsets of urothelial bladder carcinoma infiltrating T cells associated with poor prognosis.", "datePublished": "2023-08-07", "url": "https://questionsmedicales.fr/article/37550396", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-39208-0" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Procédures de chirurgie opératoire", "item": "https://questionsmedicales.fr/mesh/D013514" }, { "@type": "ListItem", "position": 3, "name": "Procédures orthopédiques", "item": "https://questionsmedicales.fr/mesh/D019637" }, { "@type": "ListItem", "position": 4, "name": "Allongement osseux", "item": "https://questionsmedicales.fr/mesh/D001852" }, { "@type": "ListItem", "position": 5, "name": "Technique d'Ilizarov", "item": "https://questionsmedicales.fr/mesh/D018889" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Technique d'Ilizarov - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Technique d'Ilizarov", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Technique d'Ilizarov", "description": "Comment diagnostiquer une fracture complexe ?\nQuels tests sont utilisés pour évaluer les déformations osseuses ?\nQuels signes indiquent une nécrose osseuse ?\nComment évaluer la longueur des os ?\nQuels symptômes nécessitent une intervention chirurgicale ?", "url": "https://questionsmedicales.fr/mesh/D018889?mesh_terms=Carcinoma,+Transitional+Cell&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Technique d'Ilizarov", "description": "Quels sont les symptômes d'une fracture ?\nComment reconnaître une infection osseuse ?\nQuels signes indiquent une mauvaise cicatrisation ?\nQuels symptômes peuvent survenir après la distraction osseuse ?\nQuels sont les effets secondaires possibles de la technique ?", "url": "https://questionsmedicales.fr/mesh/D018889?mesh_terms=Carcinoma,+Transitional+Cell&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Technique d'Ilizarov", "description": "Comment prévenir les fractures chez les sportifs ?\nQuelles mesures prendre pour éviter les infections post-chirurgicales ?\nComment éviter les complications après une chirurgie osseuse ?\nQuels conseils pour une bonne cicatrisation osseuse ?\nComment prévenir les déformations osseuses chez les enfants ?", "url": "https://questionsmedicales.fr/mesh/D018889?mesh_terms=Carcinoma,+Transitional+Cell&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Technique d'Ilizarov", "description": "Comment fonctionne la technique d'Ilizarov ?\nQuels types de fractures sont traités par cette technique ?\nQuel est le rôle de la distraction osseuse ?\nQuels soins post-opératoires sont nécessaires ?\nCombien de temps dure le traitement avec la technique d'Ilizarov ?", "url": "https://questionsmedicales.fr/mesh/D018889?mesh_terms=Carcinoma,+Transitional+Cell&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Technique d'Ilizarov", "description": "Quelles sont les complications possibles de la technique d'Ilizarov ?\nComment gérer une infection après la chirurgie ?\nQuels signes indiquent une complication grave ?\nComment prévenir les douleurs chroniques après la chirurgie ?\nQuels sont les risques de non-consolidation osseuse ?", "url": "https://questionsmedicales.fr/mesh/D018889?mesh_terms=Carcinoma,+Transitional+Cell&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Technique d'Ilizarov", "description": "Quels facteurs augmentent le risque de fractures ?\nComment le tabagisme influence-t-il la cicatrisation osseuse ?\nQuels médicaments peuvent affecter la guérison osseuse ?\nComment l'alimentation influence-t-elle la santé osseuse ?\nQuels antécédents médicaux augmentent les risques de complications ?", "url": "https://questionsmedicales.fr/mesh/D018889?mesh_terms=Carcinoma,+Transitional+Cell&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une fracture complexe ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen clinique et des imageries comme les radiographies sont nécessaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les déformations osseuses ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des radiographies et des IRM peuvent être utilisés pour évaluer les déformations." } }, { "@type": "Question", "name": "Quels signes indiquent une nécrose osseuse ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Douleur persistante, gonflement et incapacité à utiliser le membre affecté." } }, { "@type": "Question", "name": "Comment évaluer la longueur des os ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des mesures radiographiques précises sont effectuées pour évaluer la longueur." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une intervention chirurgicale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Douleur intense, déformation sévère ou incapacité fonctionnelle persistante." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une fracture ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Douleur aiguë, gonflement, déformation et incapacité à bouger le membre." } }, { "@type": "Question", "name": "Comment reconnaître une infection osseuse ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur, douleur et écoulement au site de la fracture ou de la chirurgie." } }, { "@type": "Question", "name": "Quels signes indiquent une mauvaise cicatrisation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Douleur persistante, mobilité limitée et déformation visible de l'os." } }, { "@type": "Question", "name": "Quels symptômes peuvent survenir après la distraction osseuse ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Douleur, gonflement et parfois des picotements au niveau du site de distraction." } }, { "@type": "Question", "name": "Quels sont les effets secondaires possibles de la technique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Inconfort, infection, et parfois des problèmes de croissance osseuse." } }, { "@type": "Question", "name": "Comment prévenir les fractures chez les sportifs ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Renforcement musculaire, échauffement adéquat et utilisation d'équipements de protection." } }, { "@type": "Question", "name": "Quelles mesures prendre pour éviter les infections post-chirurgicales ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène, suivre les instructions médicales et surveiller les signes d'infection." } }, { "@type": "Question", "name": "Comment éviter les complications après une chirurgie osseuse ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Suivre les recommandations médicales, éviter les activités à risque et faire des contrôles réguliers." } }, { "@type": "Question", "name": "Quels conseils pour une bonne cicatrisation osseuse ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, repos suffisant et éviter le tabac favorisent la cicatrisation." } }, { "@type": "Question", "name": "Comment prévenir les déformations osseuses chez les enfants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Surveiller la croissance, encourager l'activité physique et consulter un médecin si nécessaire." } }, { "@type": "Question", "name": "Comment fonctionne la technique d'Ilizarov ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle utilise un cadre externe pour stabiliser l'os et favoriser la régénération." } }, { "@type": "Question", "name": "Quels types de fractures sont traités par cette technique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Fractures complexes, fractures non consolidées et déformations osseuses." } }, { "@type": "Question", "name": "Quel est le rôle de la distraction osseuse ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'allonger l'os progressivement en créant un nouvel os entre les segments." } }, { "@type": "Question", "name": "Quels soins post-opératoires sont nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Surveillance des signes d'infection, gestion de la douleur et rééducation." } }, { "@type": "Question", "name": "Combien de temps dure le traitement avec la technique d'Ilizarov ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut durer de plusieurs semaines à plusieurs mois selon le cas." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la technique d'Ilizarov ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Infections, douleurs chroniques, et problèmes de consolidation osseuse." } }, { "@type": "Question", "name": "Comment gérer une infection après la chirurgie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Antibiotiques et soins locaux sont nécessaires pour traiter l'infection efficacement." } }, { "@type": "Question", "name": "Quels signes indiquent une complication grave ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, douleur intense et écoulement purulent au site opératoire." } }, { "@type": "Question", "name": "Comment prévenir les douleurs chroniques après la chirurgie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une rééducation précoce et une gestion adéquate de la douleur sont essentielles." } }, { "@type": "Question", "name": "Quels sont les risques de non-consolidation osseuse ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Mauvaise circulation sanguine, infection ou mauvaise technique chirurgicale peuvent causer cela." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de fractures ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, l'ostéoporose et les activités sportives à risque augmentent ce risque." } }, { "@type": "Question", "name": "Comment le tabagisme influence-t-il la cicatrisation osseuse ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme retarde la cicatrisation et augmente le risque d'infections post-opératoires." } }, { "@type": "Question", "name": "Quels médicaments peuvent affecter la guérison osseuse ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les corticostéroïdes et certains anti-inflammatoires peuvent retarder la guérison." } }, { "@type": "Question", "name": "Comment l'alimentation influence-t-elle la santé osseuse ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en calcium et vitamine D est essentielle pour la santé osseuse." } }, { "@type": "Question", "name": "Quels antécédents médicaux augmentent les risques de complications ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Antécédents de maladies osseuses, diabète ou troubles circulatoires augmentent les risques." } } ] } ] }

Sources (10000 au total)

Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors.

To clarify the impact of body mass index (BMI) on treatment outcomes including survival, tumor response, and adverse events (AEs) in patients with advanced renal cell carcinoma (RCC) or urothelial car... We retrospectively evaluated 309 patients with advanced RCC or UC who received ICIs between September 2016 and July 2021. The patients were divided into high- (i.e., ≥25 kg/m... Overall, 57 patients (18.4%) were classified into the high-BMI group. In RCC patients treated with ICIs as first-line therapy or UC treated with pembrolizumab, progression-free survival (PFS) (p = 0.3... BMI was not associated with survival or response rates of advanced RCC or UC patients treated with ICIs in an Asian population. AEs might frequently develop in high-BMI patients with RCC in nivolumab ...

The osteoclast-type giant cell rich carcinoma of urinary bladder: A case series.

Osteoclast-type giant cell-rich carcinomas (OGCRCs) of urinary bladder are extremely rare, aggressive tumors that are often diagnosed as undifferentiated carcinomas. The morphology overlaps with other... Five cases of OGCRCs of bladder were retrospectively reviewed. Clinical presentation, histomorphology, ancillary tests, treatment and follow-up data were retrieved and analyzed.... All patients were adult males (age range 63-86 years) and presented with painless gross hematuria. All cases showed biphasic morphology with polygonal to epithelioid to spindle mononuclear cells (MCs)... OGCRC is an extremely rare and potentially aggressive malignant neoplasm of bladder. Most cases have associated conventional in-situ or invasive UC supporting undifferentiated or de-differentiated nat...

The Association of P53, CK29, and FGFR3 Overexpression with the Characteristics of Urothelial Cell Carcinoma of the Bladder.

The aim of this study was to investigate the association between the overexpression of tumor protein (P53), cytokeratin 20 (CK20), fibroblast growth factor receptor 3 (FGFR3), biomarkers and the gradi... A cross-sectional study was conducted using 413 samples of Iranian patients diagnosed with UCC of the bladder. The tissue microarray technique was used to evaluate the patterns of tumor tissue. Two pa... The results showed that P53 was a predictor of a high-grade pattern (the area under the curve (AUC)=0.620) with a best cut-off value of 95.0 using the receiver operating characteristic (ROC) curve. CK... The study findings indicate that the intensity and percentage of cell staining for P53 and CK20 in the UCC of the bladder can aid in differentiating the grading patterns. The tendency of tumor relapse...

Novel T-cell signature based on cell pair algorithm predicts survival and immunotherapy response for patients with bladder urothelial carcinoma.

T-cell-T-cell interactions play important roles in the regulation of T-cells' cytotoxic function, further impacting the anti-tumor efficacy of immunotherapy. There is a lack of comprehensive studies o... More than 3,400 BLCA patients were collected and used in the present study. The ssGSEA algorithm was applied to calculate the infiltration level of 19 T-cell types. A cell pair algorithm was applied t... Nineteen T-cell types were collected; 171 T-cell pairs (TCPs) were established, of which 26 were picked out by the least absolute shrinkage and selection operator (LASSO) analysis. Based on these TCPs... All in all, we constructed and validated TCRPI based on cell pair algorithms in this study, which might put forward some new insights to increase the survival estimation and clinical response to immun...

Single-cell transcriptomic analysis of tumor heterogeneity and intercellular networks in human urothelial carcinoma.

Heterogeneity of tumor cells and the tumor microenvironment (TME) is significantly associated with clinical outcomes and treatment responses in patients with urothelial carcinoma (UC). Comprehensive p... Seven patients with UC were included who underwent curative surgery at our hospital between July 2020 and October 2020. We performed single-cell RNA sequencing (scRNA-seq) analysis in seven tumors wit... Unsupervised t-distributed stochastic neighbor embedding clustering analysis identified ten main cellular subclusters in urothelial tissues. Of them, seven urothelial subtypes were noted, and malignan... Our scRNA-seq analysis clarified intra-tumoral heterogeneity and delineated the pro-tumoral and immunosuppressive microenvironment in UC tissues, which may provide novel therapeutic targets....

Comparison of the risks of renal cell carcinoma or urothelial cancer between hemodialysis and peritoneal dialysis patients.

This study is to compare risks of developing renal cell carcinoma or urothelial cancer between hemodialysis (HD) and peritoneal dialysis (PD) patients.... The age-, sex-, and index year-matched patients with newly diagnosed end-stage kidney disease (ESKD) undergoing dialysis [HD (N = 22,587) or PD (N = 11,547)] from 2000 to 2015 in Taiwan were identifie... The incidence rate of renal cell carcinoma was higher in the PD group than in age-, sex-, and index year-matched HD group (11.5 versus 5.52 per 10,000 person-years), with an adjusted HR of 2.15 (95% c... ESKD patients undergoing PD are at a higher risk of developing renal cell carcinoma than those on HD, but risks of developing urothelial cancer are similar among the two groups....